Skip to content

Soothe Your Tinnitus

Scientifically proven tinnitus treatment technology.

Find a Clinic
Lenire Home Page

How Lenire Treats Tinnitus

83% of Patients Recommend Lenire 4

At-Home Tinnitus Treatment Lenire
Life Changing Solution

Tinnitus can be distressing and cause sleep, social and concentration issues. Lenire soothes tinnitus so you can live life your way.

Lenire Tinnitus Treatment Device Close
Safe and Effective

Lenire’s dual mode stimulation has been proven safe and more effective than sound-only therapy for moderate or worse tinnitus. 3

Lenire Tinnitus Treatment Device
Trusted by Specialists

Lenire works with hearing care and tinnitus experts worldwide to ensure patients receive the best quality of care.

What is Lenire?

Lenire is first and only dual mode technology for the treatment of tinnitus granted US FDA approval. Large scale clinical trial results show the device to be a safe and effective tinnitus treatment. 4

What is Lenire?

Patient Success Stories

Lenire Softened Edward’s Tinnitus After 4-Weeks

“Before Lenire, tinnitus was very bad at night-time or in the morning, that’s when it was at its worst.”

Edward, Clinical Trial Participant

Lenire Success Stories

Lenire Helped Dorothy Unwind to Sleep

“Lenire was very easy to use. When I saw it first I was a bit wary but then when I used it, it was very simple.”

Dorothy, Clinical Trial Participant

Lenire Success Stories

Lenire Helped Ronnie Regain Calmness

“Since I started Lenire, I’m far more calm and relaxed. My focus on the sound isn’t there as much.”

Ronnie, Clinical Trial Participant

Lenire Success Stories

Lenire Lowered Niall’s Tinnitus from a 10 to a 3

“I don’t think anybody understands how tinnitus affects your life. Some days it can be very hard. It’s very hard to relax. It’s very hard to enjoy life sometimes.”

Niall, Clinical Trial Participant

Lenire Success Stories

What is Tinnitus?

Tinnitus affects up to 15% of people and can be experienced as a ringing or buzzing in the ears. A person with tinnitus hears noise when there is no external source.

Learn About Tinnitus

Proven in Three Large Clinical Trials

FDA Approved. Independently Verified. Real World Validated.

Lenire Clinical Trial 1
First Clinical Trial

80% of Lenire’s first clinical trial patients had a reduction in tinnitus severity that sustained for at least 12 months after treatment. 1

Lenire Clinical Trial 2
Second Clinical Trial

91% of Lenire’s second clinical trial patients had a reduction in tinnitus severity that sustained for at least 12 months after treatment. 2

Lenire Clinical Trial 3
Third Clinical Trial

Majority of patients with moderate or worse tinnitus had significant relief using Lenire when audio-only had no meaningful impact.3

Frequently Asked Questions

  • What is tinnitus?

    Tinnitus is the perception of sound when there is no external source. Tinnitus is a very common condition that affects 10 – 15% of people. At present, there is no cure for tinnitus. However, Lenire has been proven to significantly reduce tinnitus severity.

  • What are the types of tinnitus?

    Generally speaking, there are two types of tinnitus: Subjective Tinnitus and Objective Tinnitus.

    Subjective Tinnitus is tinnitus that only the person themselves can hear. This is the most common type of tinnitus, encompassing any and all of the aforementioned symptoms.

    Objective tinnitus is tinnitus that your GP can hear when they do an examination and put a stethoscope to the ear. This rare type of tinnitus may be caused by a blood vessel problem or ear muscle contractions.

    Lenire is a bimodal neuromodulation treatment that focuses on Subjective Tinnitus; as such, we will refer only to Subjective Tinnitus below.

  • What do I do if I have tinnitus?

    For a lot of people, identifying the specific cause of their tinnitus symptoms proves difficult.

    For this reason, it’s important that patients experiencing tinnitus go and see their GP for a full examination in order to diagnose the underlying cause. In some cases, resolving the cause may alleviate the perception of tinnitus, such as an ear infection.

    If the GP cannot find an underlying cause, patients may be referred to an ENT Consultant for further investigation. An MRI / CT scan may be carried out to further clarify the problem.

    Patients may also be referred on to an audiologist to have their hearing assessed.

    Audiologists who specialise in tinnitus can also explain to people the different types of treatments and management techniques available and highlight those which they deem as most suitable to a particular individual.

  • What are the causes of tinnitus?

    Hearing loss, as a result of ageing, is the most common cause of tinnitus.

    Other common causes include eardrum perforation, middle ear infection, Ménière’s Disease, sudden exposure to loud noise, certain medications, head injury, temporomandibular joint disorder (TMJ) and stress.

    Less commonly, tinnitus is linked to hearing loss caused by a blockage or ear condition that affects the outer or middle ear and stops sound waves from passing into the inner ear.

  • Is there a cure for tinnitus?

    No. However, Lenire is clinically proven to provide relief from tinnitus. Lenire’s clinical trials have demonstrated that the medical device is effective at soothing tinnitus and can provide long term relief. Additionally, Lenire has been proven to be more effective than audio-only therapy at soothing tinnitus.

Find a Clinic

Neuromod Devices has expert Partner Clinics across America, Europe, and the United Kingdom. Use the Find a Clinic Map to start your treatment with Lenire.

Find a Clinic

Resources and Success Stories

How the Device Works

Learn how it works and how our three large-scale clinical trials were designed.

Patient Testimonials

Watch this video to hear patient success stories from our clinical trials.

Webinar: Managing Tinnitus

Learn how you can manage tinnitus and find more resources on the blog.

1. TENT-A1 Conlon et al., Sci. Transl. Med. 12, eabb2830 (2020)
2. TENT-A2: Conlon et al., Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial, Sci Rep.
3. TENT-A3: Clinical trial data in preparation for independent publication:
4. Aggregate: TENT-A1, TENT-A2, TENT-A3 aggregate clinical trial results.
Note 1: All statistics based on compliant patients. Patient compliance criteria is detailed in Lenire’s clinical trial design.
Note 2: TENT-A1/TENT-A2 were not considered by the United States of America FDA as part of Lenire’s FDA Grant and, as such, applies solely to outside the US.